| ID Source | ID |
|---|---|
| PubMed CID | 53230 |
| CHEMBL ID | 354669 |
| CHEBI ID | 82456 |
| SCHEMBL ID | 3293306 |
| MeSH ID | M0113262 |
| Synonym |
|---|
| 1,3-dinitropyrene |
| pyrene, 1,3-dinitro- |
| brn 5292115 |
| ccris 3381 |
| 1,3-dinitropyrene, 99% |
| CHEMBL354669 |
| 1,3-dinitro-pyrene |
| chebi:82456 , |
| C19408 |
| 75321-20-9 |
| d09d9l0924 , |
| unii-d09d9l0924 |
| AKOS015913367 |
| SCHEMBL3293306 |
| dinitropyrene, 1,3- |
| 1,3-dinitropyrene [iarc] |
| DTXSID5074975 |
| pyrene, 1,3-dinitro-; 1,3-dinitropyrene |
| 1,3-dinitropyrene 100 microg/ml in toluene |
| Q27155954 |
| Class | Description |
|---|---|
| pyrenes | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID23442 | Partition coefficient (logP) | 1991 | Journal of medicinal chemistry, Feb, Volume: 34, Issue:2 | Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity. |
| AID200690 | Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol | 1991 | Journal of medicinal chemistry, Feb, Volume: 34, Issue:2 | Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 19 (45.24) | 18.7374 |
| 1990's | 17 (40.48) | 18.2507 |
| 2000's | 6 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (15.61) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (4.76%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 40 (95.24%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Relationship Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|
| dinitrochlorobenzene Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.. 1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions. | 3.07 | 1 | 0 | C-nitro compound; monochlorobenzenes | allergen; epitope; sensitiser |
| 4-nitrobenzaldehyde 4-nitrobenzaldehyde: RN given refers to parent cpd. 4-nitrobenzaldehyde : A C-nitro compound that is benzaldehyde substituted at the para-position with a nitro group. | 3.07 | 1 | 0 | benzaldehydes; C-nitro compound | |
| nitrates Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. | 1.97 | 1 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | |
| nitric acid Nitric Acid: Nitric acid (HNO3). A colorless liquid that is used in the manufacture of inorganic and organic nitrates and nitro compounds for fertilizers, dye intermediates, explosives, and many different organic chemicals. Continued exposure to vapor may cause chronic bronchitis; chemical pneumonitis may occur. (From Merck Index, 11th ed). nitric acid : A nitrogen oxoacid of formula HNO3 in which the nitrogen atom is bonded to a hydroxy group and by equivalent bonds to the remaining two oxygen atoms. | 1.97 | 1 | 0 | nitrogen oxoacid | protic solvent; reagent |
| toluene methylbenzene : Any alkylbenzene that is benzene substituted with one or more methyl groups. | 1.98 | 1 | 0 | methylbenzene; toluenes; volatile organic compound | cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent |
| 2,4-dinitrophenol 2,4-Dinitrophenol: A toxic dye, chemically related to trinitrophenol (picric acid), used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. (Stedman, 26th ed). dinitrophenol : Members of the class of nitrophenol carrying two nitro substituents.. 2,4-dinitrophenol : A dinitrophenol having the nitro groups at the 2- and 4-positions. | 7.03 | 1 | 0 | dinitrophenol | allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor |
| 7-nitroindazole 7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure | 3.07 | 1 | 0 | ||
| benzo(a)pyrene Benzo(a)pyrene: A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.. benzo[a]pyrene : An ortho- and peri-fused polycyclic arene consisting of five fused benzene rings. | 1.97 | 1 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mouse metabolite |
| metronidazole Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.. metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. | 3.07 | 1 | 0 | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic |
| niridazole Niridazole: An antischistosomal agent that has become obsolete. | 3.07 | 1 | 0 | 1,3-thiazoles; C-nitro compound | |
| dinitrofluorobenzene Dinitrofluorobenzene: Irritants and reagents for labeling terminal amino acid groups.. 1-fluoro-2,4-dinitrobenzene : The organofluorine compound that is benzene with a fluoro substituent at the 1-position and two nitro substituents in the 2- and 4-positions. | 3.07 | 1 | 0 | C-nitro compound; organofluorine compound | agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent |
| 1-nitronaphthalene 1-nitronaphthalene: RN given refers to cpd with locant for nitro moiety in 1 position. 1-nitronaphthalene : A mononitronaphthalene substituted by a nitro group at position 1.. mononitronaphthalene : A nitronaphthalene carrying a single nitro group at unspecified position.. nitronaphthalene : A nitroarene that is naphthalene substituted by at least one nitro group. | 3.07 | 1 | 0 | mononitronaphthalene | environmental contaminant; mouse metabolite |
| 1-chloro-2-nitrobenzene [no description available] | 3.07 | 1 | 0 | C-nitro compound; monochlorobenzenes | |
| 2,5-dichloronitrobenzene [no description available] | 3.07 | 1 | 0 | ||
| 2-nitroanisole 2-nitroanisole : A member of the class of 2-nitroanisoles that is anisole in which one of the hydrogens ortho to the methoxy group is replaced by a nitro group. | 3.07 | 1 | 0 | 2-nitroanisoles | carcinogenic agent |
| 4-nitrobiphenyl 4-nitrobiphenyl: structure given in first source | 3.07 | 1 | 0 | biphenyls | |
| 2,4-dinitroaniline 2,4-dinitroaniline : A nitroaniline consisting of an aniline core having two nitro substituents located at the 2- and 4-positions. | 3.07 | 1 | 0 | nitroaniline | |
| nitrobenzene nitrobenzene : A nitroarene consisting of benzene carrying a single nitro substituent. An industrial chemical used widely in the production of aniline. | 3.07 | 1 | 0 | nitroarene; nitrobenzenes | |
| 1,2-dichloro-4-nitrobenzene [no description available] | 3.07 | 1 | 0 | ||
| 3-dinitrobenzene dinitrobenzene : Any member of the class of nitrobenzenes that consists of a benzene ring substituted by two nitro groups. A closed class.. 1,3-dinitrobenzene : A dinitrobenzene that is benzene disubstituted at positions 1 and 3 with nitro groups. | 3.07 | 1 | 0 | dinitrobenzene | neurotoxin |
| 4-chloronitrobenzene [no description available] | 3.07 | 1 | 0 | C-nitro compound | |
| 4-nitroanisole 4-nitroanisole: dye intermediate; organic synthesis; structure. 4-nitroanisole : A member of the class of 4-nitroanisoles that is anisole in which one the hydrogen meta to the methoxy group is replaced by a nitro group. | 3.07 | 1 | 0 | 4-nitroanisoles | |
| 4-nitroacetophenone 4-nitroacetophenone : A member of the class of acetophenones that is acetophenone substituted at the para-position by a nitro group. | 3.07 | 1 | 0 | acetophenones; C-nitro compound | |
| 1,4-dinitrobenzene 1,4-dinitrobenzene : A dinitrobenzene carrying nitro groups at positions 1 and 4. | 3.07 | 1 | 0 | dinitrobenzene | |
| 2,4-dinitroanisole 2,4-dinitroanisole : A member of the class of dinitroanisoles that is 2-nitroanisole in which the hydrogen para to the methoxy group is replaced by a second nitro group. | 3.07 | 1 | 0 | dinitroanisoles | explosive |
| 2,4,7-trinitrofluorenone 2,4,7-trinitrofluorenone: structure | 3.07 | 1 | 0 | ||
| 1,2-dinitrobenzene [no description available] | 3.07 | 1 | 0 | dinitrobenzene | |
| 2-nitrobenzaldehyde 2-nitrobenzaldehyde: structure given in first source. 2-nitrobenzaldehyde : Benzaldehyde substituted at the ortho-position with a nitro group. | 3.07 | 1 | 0 | benzaldehydes; C-nitro compound | |
| 2-nitronaphthalene 2-nitronaphthalene : A mononitronaphthalene carrying a nitro group at position 2. | 3.07 | 1 | 0 | mononitronaphthalene | |
| 9-nitroanthracene 9-nitroanthracene: RN given refers to cpd with locant for nitro moiety in 5 position | 3.07 | 1 | 0 | anthracenes | |
| 5-nitroacenaphthene [no description available] | 3.07 | 1 | 0 | nitronaphthalene | |
| erythropoietin 1,5-dinitronaphthalene: structure in first source. 1,5-dinitronaphthalene : A dinitronaphthalene carrying nitro groups at positions 1 and 5. | 3.07 | 1 | 0 | dinitronaphthalene | genotoxin |
| 1,3-dinitronaphthalene 1,3-dinitronaphthalene: structure given in first source | 3.07 | 1 | 0 | dinitronaphthalene | |
| 5-nitroquinoline [no description available] | 3.07 | 1 | 0 | ||
| 2-nitrofluorene 2-nitrofluorene: RN given refers to cpd with locant with nitro moiety in 2 position. 2-nitrofluorene : A nitroarene that is fluorene substituted by a nitro group at position 2. | 3.07 | 1 | 0 | nitroarene | carcinogenic agent; mutagen |
| 2,4-dichloro-1-nitrobenzene [no description available] | 3.07 | 1 | 0 | ||
| 5-nitro-2-furaldehyde [no description available] | 3.07 | 1 | 0 | C-nitro compound; furans | |
| 2-nitropyrene [no description available] | 3.07 | 1 | 0 | pyrenes | |
| 3-nitrofluoranthene 3-nitrofluoranthene: environmental carcinogen from diesel exhaust | 3.47 | 2 | 0 | nitronaphthalene | |
| 2-amino-7-nitrofluorene 2-amino-7-nitrofluorene: structure in first source | 3.07 | 1 | 0 | ||
| 2-bromo-4,6-dinitroaniline 2-bromo-4,6-dinitroaniline: used in synthesis of commercially significant monoazo dyes | 3.07 | 1 | 0 | ||
| 5-nitroindazole [no description available] | 3.07 | 1 | 0 | ||
| 2,7-dinitrofluorene [no description available] | 3.07 | 1 | 0 | ||
| 1-nitropyrene [no description available] | 5.42 | 20 | 0 | nitroarene | carcinogenic agent |
| nsc 520594 [no description available] | 3.07 | 1 | 0 | ||
| 2-hydroxy-7-nitrofluorene 2-hydroxy-7-nitrofluorene: structure in first source | 3.07 | 1 | 0 | ||
| 6-nitrochrysene 6-nitrochrysene: RN given refers to cpd with locant for nitro group in position 6 | 3.47 | 2 | 0 | carbopolycyclic compound | |
| 6-nitroindazole [no description available] | 3.07 | 1 | 0 | ||
| 2-nitrofluoranthene [no description available] | 3.07 | 1 | 0 | ||
| 7-nitrobenzanthracene [no description available] | 3.47 | 2 | 0 | phenanthrenes | |
| 3,9-dinitrofluoranthene [no description available] | 3.47 | 2 | 0 | nitronaphthalene | |
| 2,7-dinitrofluorenone 2,7-dinitrofluorenone: structure given in first source | 3.07 | 1 | 0 | ||
| 1,6-dinitropyrene [no description available] | 5.91 | 33 | 0 | pyrenes | |
| 1,8-dinitropyrene [no description available] | 5.93 | 34 | 0 | pyrenes | |
| 6-nitrobenzo(a)pyrene [no description available] | 3.07 | 1 | 0 | ortho- and peri-fused polycyclic arene | |
| 1-nitrobenzo(a)pyrene [no description available] | 3.47 | 2 | 0 | ||
| 3-nitrobenzo(a)pyrene [no description available] | 3.47 | 2 | 0 | ||
| 3,7-dinitrofluoranthene [no description available] | 3.47 | 2 | 0 | nitronaphthalene | |
| 4-nitropyrene [no description available] | 3.07 | 1 | 0 | pyrenes | |
| 3-nitroperylene 3-nitroperylene: RN given refers to cpd with nitro group in position 3 | 3.07 | 1 | 0 | phenanthrenes | |
| 2-iodosobenzoic acid ortho-iodosylbenzoic acid : A benzoic acid compound having an iodosyl substituent at the ortho-position. | 1.97 | 1 | 0 | benzoic acids; organoiodine compound | EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor |
| 1-nitro-2,4-difluorobenzene 1-nitro-2,4-difluorobenzene: standard antigen; structure | 3.07 | 1 | 0 | ||
| 5-nitroisoquinoline [no description available] | 3.07 | 1 | 0 | ||
| 9-nitrophenanthrene 9-nitrophenanthrene: RN given refers to parent cpd; | 3.07 | 1 | 0 | ||
| 5-nitro-1,10-phenanthroline 5-nitro-1,10-phenanthroline: structure in first source | 3.07 | 1 | 0 | ||
| 1-fluoro-2-nitrobenzene 1-fluoro-2-nitrobenzene: structure given in first source | 3.07 | 1 | 0 | ||
| 2-nitrobenzimidazole 2-nitrobenzimidazole: RN given refers to parent cpd | 3.07 | 1 | 0 | ||
| 1,n(6)-ethenodeoxyadenosine [no description available] | 2.03 | 1 | 0 | purines | |
| 1-nitro-8-nitrosopyrene 1-nitro-8-nitrosopyrene: structure given in first source | 1.97 | 1 | 0 | ||
| ouabain Ouabain: A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.. cardiac glycoside : Steroid lactones containing sugar residues that act on the contractile force of the cardiac muscles.. ouabain : A steroid hormone that is a multi-hydroxylated alpha-L-rhamnosyl cardenoloide. It binds to and inhibits the plasma membrane Na(+)/K(+)-ATPase (sodium pump). It has been isolated naturally from Strophanthus gratus. | 2.37 | 2 | 0 | 11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone | anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite |
| acetyl coenzyme a Acetyl Coenzyme A: Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. | 2.37 | 2 | 0 | acyl-CoA | acyl donor; coenzyme; effector; fundamental metabolite |
| nadp [no description available] | 1.96 | 1 | 0 | ||
| nitrobenzanthrone 3-nitrobenzanthrone: mutagenic environmental contaminant; structure in first source | 2.01 | 1 | 0 | phenanthrenes | |
| 2,4-dinitrophenylhydrazine 2,4-dinitrophenylhydrazine: structure. 2,4-dinitrophenylhydrazine : A C-nitro compound that is phenylhydrazine substituted at the 2- and 4-positions by nitro groups. | 3.07 | 1 | 0 | C-nitro compound; phenylhydrazines | reagent |
| 2-nitro-4-phenylenediamine 2-nitro-4-phenylenediamine: 2-nitro-1,4-benzenediamine; RN given refers to parent cpd. 2-nitro-p-phenylenediamine : A primary amino compound that is p-phenylenediamine in which one of the hydrogens attached to the benzene ring is replaced by a nitro group. It is a cosmetic hair dye intermediate that is used in permanent hair colouring products (diluted 1:1 with an oxidising agent prior to application). | 3.07 | 1 | 0 | C-nitro compound; primary amino compound | |
| 5-Nitroisatin [no description available] | 3.07 | 1 | 0 | indoles | anticoronaviral agent |
| 2-amino-5-nitrophenol 2-amino-5-nitrophenol: RN & structure given in first source | 3.07 | 1 | 0 | 3-nitrophenols | |
| 1,2-diamino-4-nitrobenzene 1,2-diamino-4-nitrobenzene: reagent for determination of selenium in milk with gas chromatograph. 4-nitro-1,2-phenylenediamine : The primary amino compound that is 1,2-phenylenediamine (o-phenylenediamine) substituted at the 4- (para-) position by a nitro group. | 3.07 | 1 | 0 | C-nitro compound; primary amino compound | |
| vitamin k semiquinone radical vitamin K semiquinone radical: found in active preparations of vitamin K-dependent carboxylase. vitamin K : Any member of a group of fat-soluble 2-methyl-1,4-napthoquinones that exhibit biological activity against vitamin K deficiency. Vitamin K is required for the synthesis of prothrombin and certain other blood coagulation factors. | 2.38 | 2 | 0 | ||
| furazolidone [no description available] | 3.07 | 1 | 0 | ||
| nitrofurazone Nitrofurazone: A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial WOUNDS AND INJURIES and skin infections. Nitrofurazone has also been administered orally in the treatment of TRYPANOSOMIASIS.. nitrofurazone : A semicarbazone resulting from the formal condensation of semicarbazide with 5-nitrofuraldehyde. A broad spectrum antibacterial drug, although with little activity against Pseudomonas species, it is used as a local application for burns, ulcers, wounds and skin infections. | 3.07 | 1 | 0 | ||
| nitrofurantoin Nitrofurantoin: A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.. nitrofurantoin : An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA. | 3.07 | 1 | 0 | imidazolidine-2,4-dione; nitrofuran antibiotic; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic | antibacterial drug; antiinfective agent; hepatotoxic agent |
| heme Heme: The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.. ferroheme : Any iron(II)--porphyrin coordination complex.. ferroheme b : Heme b in which the iron has oxidation state +2.. heme : A heme is any tetrapyrrolic chelate of iron. | 1.96 | 1 | 0 | ||
| nitrophenols Nitrophenols: PHENOLS carrying nitro group substituents. | 1.98 | 1 | 0 | ||
| methylnitronitrosoguanidine Methylnitronitrosoguanidine: A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties.. N-methyl-N'-nitro-N-nitrosoguanidine : An N-nitroguanidine compound having nitroso and methyl substituents at the N'-position | 1.97 | 1 | 0 | nitroso compound | alkylating agent |
| phosphorus radioisotopes Phosphorus Radioisotopes: Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. | 1.97 | 1 | 0 |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Hepatocellular Carcinoma [description not available] | 0 | 2.4 | 2 | 0 |
| Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 2.4 | 2 | 0 |
| EHS Tumor [description not available] | 0 | 1.96 | 1 | 0 |
| Papilloma, Squamous Cell [description not available] | 0 | 1.96 | 1 | 0 |
| Cancer of Skin [description not available] | 0 | 1.96 | 1 | 0 |
| Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) | 0 | 1.96 | 1 | 0 |
| Skin Neoplasms Tumors or cancer of the SKIN. | 0 | 1.96 | 1 | 0 |
| Chromosome Deletion Actual loss of portion of a chromosome. | 0 | 1.98 | 1 | 0 |
| Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) | 0 | 2.39 | 2 | 0 |
| Cancer of Liver [description not available] | 0 | 1.98 | 1 | 0 |
| Experimental Hepatoma [description not available] | 0 | 1.98 | 1 | 0 |
| Liver Neoplasms Tumors or cancer of the LIVER. | 0 | 1.98 | 1 | 0 |
| Alcoholic Intoxication An acute brain syndrome which results from the excessive ingestion of ETHANOL or ALCOHOLIC BEVERAGES. | 0 | 1.98 | 1 | 0 |
| Adenocarcinoma, Basal Cell [description not available] | 0 | 1.97 | 1 | 0 |
| Experimental Leukemia [description not available] | 0 | 2.37 | 2 | 0 |
| Angioma, Sclerosing [description not available] | 0 | 2.66 | 3 | 0 |
| Adenofibroma A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed) | 0 | 1.97 | 1 | 0 |
| Experimental Mammary Neoplasms [description not available] | 0 | 2.66 | 3 | 0 |
| Adenocarcinoma A malignant epithelial tumor with a glandular organization. | 0 | 1.97 | 1 | 0 |
| Histiocytoma, Benign Fibrous A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747) | 0 | 2.66 | 3 | 0 |
| Abnormalities, Autosome [description not available] | 0 | 1.97 | 1 | 0 |
| Experimental Neoplasms [description not available] | 0 | 4.13 | 6 | 0 |
| Leucocythaemia [description not available] | 0 | 1.97 | 1 | 0 |
| Animal Mammary Carcinoma [description not available] | 0 | 1.97 | 1 | 0 |
| Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) | 0 | 1.97 | 1 | 0 |
| Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 1.96 | 1 | 0 |
| Cancer of the Vulva [description not available] | 0 | 1.96 | 1 | 0 |
| Vulvar Neoplasms Tumors or cancer of the VULVA. | 0 | 1.96 | 1 | 0 |